myelotoxicity was greater using ebap than in the earlier reported program with vincristine , carmustine , doxorubicin , and prednisone , and in the absence of higher response rates does not support the use of vindesine over vincristine in combination programs using nitrosoureas , anthracyclines , and prednisone .
C0058894
ebap
C0007257
carmustine